 |
|
|
| |
Effect of Baseline NS5A Polymorphisms on Virologic Response to the All-Oral Combination of Daclatasvir + Sofosbuvir ± Ribavirin in Patients With Chronic HCV Infection
|
| |
| |
Reported by Jules Levin
The International Liver Congress™ 2014
49th Annual Meeting of the European Association for the Study of the Liver
London, UK, April 9-13, 2014
McPhee F,1 Zhou N,1 Yang X,1 Hernandez D,1 Chiarella J,2 Kozal M2
1Bristol Myers Squibb, Wallingford, CT, USA
2Yale University School of Medicine, New Haven, CT, USA
|
| |
|
|
|
|
|
